New pill aims to slow cancer growth while easing side effects
NCT ID NCT07354919
Summary
This study is testing whether a drug called axelopran can help control advanced cancers of the lung, breast, pancreas, and prostate in patients who are taking opioid pain medication. Researchers want to see if the drug can slow tumor growth, improve bowel function, and reduce inflammation. Participants will take the oral drug daily for up to a year while doctors monitor their cancer with scans and blood tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
HealthPartners Cancer Center at Regions Hospital
Saint Paul, Minnesota, 55101, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
HealthPartners Frauenshuh Cancer Research Center
Saint Louis Park, Minnesota, 55426, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.